SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet (GOOG) is trending as discussions revolve around its AI capabilities, especially the Gemini 3 model, and potential market dominance. Community members are weighing bullish and bearish perspectives, with some pointing to new all-time highs and others anticipating a pullback. A multi-million dollar NATO cloud services deal has also sparked interest.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus is trending amid discussions about its acquisition of Star 26 Capital and potential synergies within the aerospace and defense sectors. Community members are actively speculating on upcoming news and a possible short squeeze, with some expressing bullish sentiment based on the company's low float and perceived undervaluation. Despite recent volatility, investors are closely monitoring the stock's movement and awaiting further developments.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

AVGO is trending as investors assess its role in the AI infrastructure buildout, particularly following positive signals from top customers and upcoming earnings. Community members are discussing its potential to outperform peers and reach new highs, with some analysts setting bullish price targets. Despite market volatility, many see this dip as a buying opportunity before the December earnings.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

OSCR is trending due to a healthcare proposal delay following congressional backlash, sparking uncertainty about ACA subsidies. Community discussions revolve around the potential impact of this delay, with some anticipating a short squeeze while others express concern about the company's future prospects. The stock's significant price movement reflects the sensitivity to policy changes within the health insurance sector.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune ($ALT) is trending amid community discussions around potential buyout speculation, particularly involving Sanofi ($SNY), and anticipation for upcoming data releases. While some investors express optimism for a short squeeze and long-term growth driven by Pemvidutide's potential in MASH and obesity, others raise concerns about data integrity and trial design, sparking debate among bulls and bears.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG Crypto, also known as Infinite Money Glitch, is trending due to its unique reward system that distributes $SOL to holders, generating excitement within its community. Community members highlight the potential for passive income through holding, regardless of price fluctuations. The broader discussion revolves around upcoming developments and the project's commitment to building innovative technology on the Solana blockchain, including its recent entry into the Cyberpunk Hackathon.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions around potential political implications and legal battles involving Donald Trump, with community members debating his influence and future prospects.  Some are focused on potential connections to ongoing investigations, while others are commenting on the stock's performance and its relationship to broader market trends and political events. The conversation reflects polarized opinions and speculation about the company's value and direction.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community discusses potential ETF impacts and future price movements. Bullish sentiment is fueled by anticipation of increased adoption and institutional interest, while some traders express caution, citing XRP's historical price action and correlation with Bitcoin. Community members are debating short-term volatility versus long-term potential.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

RYCEY is trending as investors digest recent price dips and a mix of positive and concerning news. Community discussions focus on critical support levels and potential for further declines, while also considering upcoming catalysts like the Jefferies Industrial Summit presentation and anticipation of new SMR contracts. Despite short-term concerns, long-term bullish sentiment remains, driven by expectations for the company's SMR technology and potential expansion in data center power solutions.

Monad

Monad is trending as it recently launched on Coinbase, generating excitement and discussion around its potential. The community is actively debating its market cap, possible price targets, and the implications of Coinbase's involvement in its initial offering. Some users express enthusiasm and long-term holding plans, while others caution about potential risks and pre-launch trading activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

MindWalk Holdings Corp. (MindWalk, Company, we or us) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO...

Shares of AI-powered breast health solutions provider iCAD, Inc. (ICAD) rocketed over 67% on Wednesday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.icadmed.com/about/news-events/press-releases/radnet-inc-to-acquire-icad-inc-to-accelerate-ai-powered-early-detection-and-diagnosis-of-breast-cancer/">said</a> it entered a definitive merger agreement with RadNet (RDNT).Diagnostic imaging services provider RadNet will acquire iCAD in an all-stock transaction where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger.Based upon RadNet’s closing price on Monday, this represents a transaction value of approximately $103 million, or approximately $3.61 per share of iCAD common stock on a fully diluted basis and an approximately 98% premium to iCAD stockholders based on iCAD’s closing stock price on Monday, the company said.The transaction is expected to close in the second or third quarter of 2025, subject to approval by iCAD stockholders. It is expected to add to RadNet’s wholly-owned unit DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countries.RadNet CEO Howard Berger said that iCAD’s ProFound Breast Health Suite and RadNet’s DeepHealth AI-powered breast screening solutions together have the power to improve patient diagnosis of breast cancer.“With over 1,500 healthcare provider locations, facilitating over eight million annual mammograms in 50 countries, iCAD’s installed base and strong sales, engineering, and marketing capabilities will provide us with immediate broad and valuable customer relationships and commercialization capabilities that can accelerate our existing DeepHealth objectives,” he said.RadNet stock fell by about 7% on Wednesday.On Stocktwits, retail sentiment around iCAD rose from ‘bearish’ to ‘extremely bullish’ over the past 24 hours while message volume jumped from ‘extremely low’ to ‘extremely high’.<figure class="image"><img style="aspect-ratio:652/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_16_at_10_23_43_AM_png_7dae918bc5.webp" alt="ICAD's Sentiment Meter and Message Volume as of 10:20 a.m. ET on April 16, 2025 | Source: Stocktwits" width="652" height="146"><figcaption>ICAD's Sentiment Meter and Message Volume as of 10:20 a.m. ET on April 16, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/ICAD">ICAD stock</a> is up by over 62% year-to-date and has more than doubled over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/travelers-q1-2025-earnings/chQPN6URbOo">Travelers Q1 2025 Earnings Beat Wall Street Estimates Despite $2.26 Billion California Wildfires Losses, Revenue Falls Short Of Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

iCAD Stock Rockets On Merger Announcement With RadNet: Retail’s Elated

Diagnostic imaging services provider RadNet will acquire iCAD in an all stock transaction where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger.

Equity

Craig-Hallum Sticks to Their Buy Rating for iCAD (ICAD)

In a report released today, Per Ostlund from Craig-Hallum maintained a Buy rating on iCAD (ICAD Research Report). The company's shares closed yes...

iCAD partners with RAD-AID to advance breast cancer detection

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)

iCAD implements ProFound AI Detection to improve mammography reading and breast cancer detection in low-resource institutions and medically underserved communitiesNASHUA, N.H., April 03, 2024...

iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detectionNASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a...

iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists

Newly released capabilities -- limiting the number of marks on a 3D view, color-coding lesion marks, and color-coding the ProFound Scorecard -- enhance radiologists' interpretability and...

Q4 2023 ICAD Inc Earnings Call Transcript

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results

Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H...

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

Clinical evidence demonstrates ProFound Detection's AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false negatives Findings reveal substantially...

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

Icad Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.05	--	--	N/A
Q2 '25	-$0.06	--	--	N/A
Q1 '25	-$0.06	-$0.02	68.00%	BEAT
Q4 '24	-$0.05	-$0.03	42.67%	BEAT
Q3 '24	-$0.08	-$0.07	15.87%	BEAT

ICAD
Icad Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest ICAD News

ICADIcad Inc